We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BARR LABS WANTS GENERIC ACTIQ RIGHTS EARLIER
BARR LABS WANTS GENERIC ACTIQ RIGHTS EARLIER
December 14, 2004
Even though the company already has been licensed by brand drugmaker Cephalon to manufacture and market the product, generic firm Barr Laboratories has filed an abbreviated new drug application (ANDA) with a paragraph IV certification for a generic version of Actiq.